RE:RE:RE:Yesterday's link was Lol it's pretty clear. The cryopharm president /ceo Keith Bushfield is a founder of neutrisci (LinkedIn) so he's well versed in our IP/ product . They pay us a yearly license fee and we get royalty payments based on sales milestones. The latest interview also mentioned that there was some cost sharing involved (most likely machinery as the same machines make all the products
https://ca.linkedin.com/in/keith-bushfield-39253b32?challengeId=AQF2-ipPznlbuAAAAXX9JcD6hdirlYlV2Dq5S2pehfutn4y4xk-1OXiP1ReZqKCitwOg6d57QwKNPmNnU2FlPUKjeZSN69wYVA&submissionId=c1f32b47-f99d-4a16-d8e5-e26cb4564802
The tabletz deal is different . It's a private label deal (sometimes called a white label deal). We provide the IP, the ingredients, the packaging , the whole finished product . They take it from their and are responsible for marketing , distributing , and billing their clients. As explained in the last interview there are minimum amounts they must take as per the contract but it's looking like they'll be taking plenty more than the minimums. We aren't out any money with them. They pay a deposit when placing order and the balance paid prior to shipping (in the interview he explained that in future they may tweek that a bit to help partner with expansion etc) I highly suggest watching the interview. Very informative and once again lays out their minimum of 4 deal models. We got abother "stay tuned new update coming" or whatever on Twitter this morning. They are either cruel or we are moments away from hitting a massive new level (something else glen said in that interview)
https://m.youtube.com/watch?feature=youtu.be&v=wTu06to2488